Anti-Gliadin sIgA / IgA ELISA Assay
The Anti-Gliadin sIgA / IgA ELISA Assay is For Research Use Only
Size: 1×96 wells
Sensitivity: 1.3 mU/g
Incubation Time: 2 hours 15 minutes
Sample Type: Stool
Sample Size: 100 mg, 100 µl
Product Developed and Manufactured in Germany
Product Support in the United States
Celiac disease is a chronic illness of the small intestinal mucous membrane. It is caused by an intolerance against gluten, which is found in many cereals. The intake of gluten-containing food leads to inflammation of the small intestinal mucous membrane. The resorption of nutrients is therefore reduced. The symptoms of the disease are reduction of weight, diarrhoea, vomiting, norexia and tiredness. The growth in children is reduced. The only therapeutic treatment is a gluten-free diet.
An untreated celiac disease has been known to increase the risk of non-Hodgkin-lymphoma and colon cancer. In five to ten percent of the patients, celiac disease is associated with diabetes mellitus type 1. Women are more often affected than men. The outcome of the disease is pronounced during infancy and in an age between 30 and 40 years.
The Eagle Biosciences Anti-Gliadin sIgA / IgA ELISA Assay kit allows for an easy, rapid and precise quantitative determination of the secretory IgA and IgA gliadin antibodies in stool. The kit includes all reagents ready to use for preparation of the samples.